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Abstract
Advanced restorative dentistry may necessitate the need 
for  surgical intervention to the infected root apex. Once access 
to the root end is achieved, the root apex is resected and filled 
with a dental restorative material. 
The materials currently in use are not satisfactory due to 
inadequate biocompatibility and failure to achieve desirable 
properties in an aqueous environment. With the introduction 
of a new material, essentially Portland cement used in the 
building industry, these desirable properties have been achieved. 
This paper reviews the methods of testing biocompatibility of 
Portland cement used in dentistry.
Introduction
In restorative dentistry materials are mainly utilized to 
replace dental tissue lost through dental caries and tooth 
preparation procedures. When a significant amount of tooth 
tissue is lost the dental pulp may be adversely affected. This 
may necessitate advanced conservative procedures involving 
extirpation of the dental pulp and obliteration of the space with 
gutta-percha and root canal sealers. Access for these procedures 
is through the tooth crown. Should this be unsuccessful, surgical 
endodontics is necessary to allow cleaning and sealing of the 
root end to prevent further infection. 
The main pre-requisites of a material to be used as a root 
end filling material are biocompatibility and the ability to set in 
an aqueous environment. Materials of choice for filling the root 
ends prior to flap repositioning include dental amalgam, glass 
ionomer cement (GIC), and intermediate restorative material 
(IRM). None of these materials is the ideal restorative material 
for the root end of a tooth. Dental amalgam is mercury-based, 
glass ionomer cements are dimensionally unstable and do not 
encourage cell growth and IRM is based on eugenol which can 
be allergenic. The maintenance of a dry field can be problematic 
during surgery and all these dental cements have to be kept dry 
until they set.
In the 1990s a new material, mineral trioxide aggregate 
(MTA) was developed at Loma Linda University as a root-
end filling material. The first publication on the use of the 
material to seal root perforations was published in 1993.1 It is 
Figure 1: Surface morphology of mineral trioxide 
aggregate showing cell monolayer over the material (x350) 
(Camilleri et al. 2004).
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commercially available as ProRoot MTA (Tulsa Dental Products, 
Tulsa, OK, USA). The use of MTA as a root-end filling material 
was identified due to the fact that the material is a hydraulic 
cement i.e. it sets in the presence of water. A dental cement that 
sets and develops its properties in the presence of moisture is 
highly desirable. Mineral trioxide aggregate (MTA) is now used 
extensively in endodontics. Two commercial forms of MTA are 
available (ProRoot MTA); namely the grey and the white MTA 
both with similar chemical and physical properties. MTA is 
essentially Portland cement (used in the building industry as 
a binder in concrete) with 4:1 proportions of bismuth oxide 
added for radiopacity.2 The material was originally reported to 
be composed of calcium and phosphate and its biocompatibility 
was attributed to its similarity to dental hard tissues.3 However 
Camilleri and co-workers4 have shown that MTA is composed 
primarily of tricalcium and dicalcium silicate, the main 
constituent elements of Portland cement, which on hydration 
produce a silicate hydrate gel and calcium hydroxide, not 
calcium phosphate as claimed by Torabinejad.2,3  
As the evidence presented by Torabinejad and co-workers2,3 
for the biocompatibility of MTA have been shown to be invalid4, 
further studies were necessary to investigate the biocompatibility 
of MTA.
Biocompatibility testing
Biocompatibility testing is performed on materials that are 
placed in the human body. Human tissue reacts to the material 
in a variety of ways depending on the material type. These special 
materials which are able to function in intimate contact with 
biological fluids or living tissue with minimal adverse reaction 
or rejection by the body are called biomaterials. The mechanism 
of tissue attachment (if any) depends on the tissue response to 
the material surface. Materials can generally be categorised into 
three classes representing the type of tissue response they elicit:
chemically inert, bioresorbable, or bioactive. 
In vitro biocompatibility of a material is usually assessed 
against two controls: a negative control material, which does not 
produce a cytotoxic response and a positive control material, 
which provides a reproducible cytotoxic response. The purpose 
of the negative control is to demonstrate background response 
while that of the positive control is to demonstrate appropriate 
test system response. Tests are performed either on the material 
itself or on material extracts. Extraction vehicles include culture 
medium with and without serum, or physiological saline. 
Materials tested should have at least one flat surface and should 
be sterilized prior to subjecting it for biocompatibility testing. 
Biocompatibility of MTA has been tested using the following 
methods:
 1. cell expression and growth5-27
 2. animal studies28-35
Cell expression and growth
The use of cell cultures in the study of endodontic materials 
was introduced by Rappaport and co-workers.36 Cell culture 
techniques use either primary cells or immortal cell lines, which 
Figure 4: Large calcium carbonate crystals (aragonite) 
deposited over the material after critical point drying x 660 
magnification (Camilleri et al. 2004)
Figure 2: Surface morphology of cement showing calcium 
phosphate crystals deposited over the surface of the material 
(x50 mag.) (Camilleri et al. 2005a)
Figure 3: Diffuse calcium carbonate crystals (calcite) 
deposited over the material after critical point drying x 250 
magnification (Camilleri et al. 2004)
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are cells derived clonally from normal or malignant cell cultures, 
usually sarcomas.37 These cells are easily cultured and they 
exhibit increased phenotypic stability with serial passages which 
results in increased reproducibility of results in independently 
conducted experiments.37 
Established cell lines have an aneuploid chromosome 
pattern and thus tend to multiply rapidly with an unlimited life 
span if appropriately sub-cultured. They are easier to culture and 
therefore the quality of the cultured cells is more predictable. 
Aneuploid cells frequently used are L929 mouse fibroblasts38, 
BHK 21 hamster fibroblasts39, HeLa human cervical carcinoma 
epithelial cells40 and NCTC 2544 human skin epithelial cells.41 
The SaOS-2 cells represent a highly differentiated cell line 
capable of inducing bone formation and are thus a model for 
osteoblastic behaviour. They are more highly differentiated and 
their growth maintains a consistent cell phenotype.42,43 These 
osteosarcoma cells closely resemble the human osteoblast in its 
ability to express high levels of bone markers. MG 63 cells are 
derived from human osteosarcoma cells, however have fewer 
characteristics of mature osteoblasts. 
Cell type
MTA and Portland cement show good induction of 
cell proliferation with the formation of a cell monolayer 
(Figure 1). Assessment of biocompatibility in vitro using 
cell culture techniques has been widely used to study the 
biocompatibility of MTA as a biomaterial. (Table 1). Cell 
types used varied from immortal cell lines to animal cells and 
fibroblasts. Cell lines are usually the preferred cell types used 
for cytological investigations. Primary osteoblasts have however 
been shown to be more appropriate for testing endodontic 
materials in cell culture as they are more sensitive and form 
mineralized nodules when exposed to differentiation media. 
As cell lines do not behave ostegenically, primary osteoblasts 
are preferred.16
Evaluation of cell  proliferation
a. Scanning electron microscopy
The method preferred for evaluation of cell proliferation 
was scanning electron microscopy (SEM) followed by enzyme 
assay. The main problem with the use of the scanning electron 
microscope in cell culture studies with MTA is the material 
reaction with the preparation media. Calcium hydroxide, a by-
product of calcium silicate hydration, reacts with phosphate 
buffered solutions producing calcium phosphate crystals over 
the material surface (Figure 2).4 Camilleri and co-workers 
showed that this artifact was responsible for Torabinejad’s 
conclusion that MTA resembled dental hard tissue. In addition 
Author and date Cell type Contact time/days Method of assessment
 
Torabinejad et al. 1995 Mouse L929 1 Agar overlay
Torabinejad et al. 1995 Mouse L929 1 Radiochromium release
Koh et al. 1997 MG 63 6 SEM
Koh et al. 1998 MG 63 1-7 SEM
Osorio et al. 1998 Gingival fibroblasts, L929 / MTT, CV assay
Mitchell et al. 1999 MG 63 2, 4, 7 SEM
Keiser et al. 2000 PDL firoblasts 1 MTT assay
Zhu et al. 2000 HOBs 1 SEM
Abdullah et al. 2002 SaOS-2 1, 2, 3 SEM
Saidon et al. 2003 Mouse L929 3 SEM
Haglund et al. 2003 Mouse L929, macrophages 3 SEM
Huang et al. 2003 U2OS  MTT assay
Perez et al. 2003 Osteoblasts, MG 63 6, 9, 13 SEM
Pistorius et al. 2003 PDL, Gingival fibroblasts 4 Cytosolic esterase activity
Camp et al. 2003 Gingival fibroblasts 1, 2, 3 fluorescence
Asrari and Lobner 2003 Neurons 12-14 enzyme assay
Balto 2004 PDL fibroblasts 1 SEM
Bonson et al. 2004 PDL, gingival fibroblasts 15 fluorescence
Pelliccioni et al. 2004 SaOS 1, 3 Assay
Camilleri et al. 2004 SaOS 1, 5, 7 SEM
Camilleri et al. 2005 HOS 1-7, 1-21 alamarBlue assay
Koulaouzidou et al.2005 L929, BHK21/C13 fibroblasts 1, 2 Sulforhodamine-B assay
Nakayama et al. 2005 Rat bone marrow cells 3 “SEM, TEM”
Moghaddame-Jafari et al. 2005 Mouse odontoblastic cells 1 Flow cytometry
Table 1: Cell type, contact time and method of assessment of the various studies conducted on MTA using cells
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critical point drying, an essential step for material preparation 
prior to viewing under the scanning electron microscope causes 
cement carbonation (Figures 3, 4).23 
b. Enzyme assay
Enzyme assay, the next most preferred method to study 
cell proliferation on mineral trioxide aggregate, would seem 
to be more reliable as it avoids material preparation. Enzyme 
assay measures the metabolic activity of cells grown over the 
materials under study. This can be done by using alamarBlue™ 
and methyltetrazolium (MTT) assay in a method outlined 
in ISO 10993-5.44 Cell proliferation is determined using a 
redox indicator that can be used to quantitatively measure 
proliferation of cells.45 As the cells grow in culture, their 
metabolic activity maintains a reducing environment in the 
surrounding culture medium, whilst growth inhibition produces 
an oxidized environment. Reduction causes colour change 
of the alamarBlueTM indicator from non-fluorescent (blue) to 
fluorescent (red). In addition the cell activity on material elusion 
can also be measured. This ensures that no toxic substances 
are leached from the material. The MTT assay46 is dependent 
on the intact activity of the mitochondrial enzyme, succinate 
dehydrogenase, which is impaired after exposure of cells to toxic 
surroundings. The test involves the conversion of a tetrazolium 
salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide an insoluble formazan product, which can be quantified 
by spectrophotometry. Due to the poor knowledge of the 
chemical constitution of MTA very few studies were published 
on the material extracts of the material. 
c. Cytokine expression
Biocompatibility can also be determined by quantifying 
the effect of the material on the normal bone physiology. Bone 
remodeling takes place in alternating phases of resorption 
and deposition. The first phase involves the recruitment and 
differentiation of the osteoblast precursors. The second phase 
is the production and mineralization of the bone matrix by the 
mature osteoblasts. The cytokines involved in bone formation 
are divided into cytokines that stimulate bone cell proliferation 
and those that have an inhibitory effect on the mature 
osteoblasts. The former include cytokines such as IL-1, tumour 
necrosis factor and macrophage-colony stimulating factor. For 
bone resorption to take place, bone formation must be halted. 
At this phase, stimulation of osteoblast precursors occurs 
in preparation for renewed bone formation. Here cytokines 
stimulate both precursor proliferation and mature osteoblast 
activity. MTA induced expression of cytokines from bone cells 
and exhibited good cell attachment. MTA caused an increase 
in IL-4 and IL-10 levels.15 Another study showed an increase in 
Interleukin 6, and 8 with no increase in levels of Interleukin 1a 
and 1ß. 9  Conversely other researchers6, 7 showed a rise of both 
IL-1a and 1ß together with IL-6 after the cells were in contact 
with the material for 144 hours. MTA increases osteocalcin 
levels47 and also preferentially induces alkaline phosphatase 
expression and activity in both periodontal ligament and 
gingival fibroblasts21 demonstrating an increase in osteoblast 
mineralizing activity. In one study where no cytokine production 
was demonstrated, cell lysis and protein denaturing around the 
MTA was observed.14
d. Other methods
The agar overlay method and radiochromium release 
methods5 were the least preferred methods to study cell 
proliferation. The main disadvantage of radiochromium release 
method is the use of radioactive isotopes.
Animal studies
Recommended methods for the evaluation of dental 
materials include a preliminary test that provides a general 
toxicity profile for the potential material and a secondary test 
that evaluates local toxicity, and a usage test in experimental 
animals. The effect of the test material on animal tissues can 
be studied by histological evaluation of the tissues involved. 
The main problem with these studies is the cost and upkeep of 
the test animals.  
Subcutaneous and intra-osseous implantation
Subcutaneous implantation of the materials in test animals 
showed MTA initially elicited severe reactions with coagulation 
necrosis and dystrophic calcification.30, 34 The reactions 
however, subsided to mostly moderate with time. Reactions 
to intraosseous implants of both materials were less intense 
than with subcutaneous implantation. The main disadvantage 
with intra-osseous implantation is that the bony cavity created 
for placement of the material implant is an artificial socket 
with no resemblance to a tooth suspended in the periodontal 
ligament. Implantation of MTA in rat connective tissue produced 
granulations birefringent to polarized light and an irregular 
structure like a bridge was observed next to the material. In 
the dentin wall tubules a layer of birefringent granulations was 
also observed.31-33 The tissue reaction to MTA implantation was 
the most favorable observed in both tibia and mandible of test 
animals, as in every specimen, it was free of inflammation. In 
the tibia, MTA was the material most often observed with direct 
bone apposition.29, 30 
Histological assessment 
of peri-radicular tissues
MTA has been used to fill root ends of teeth in experimental 
animals. The teeth and surrounding bone were then resected 
and the presence of inflammation around the material used as a 
marker of material biocompatibility.  MTA at the peri-radicular 
surgical site produced less periradicular inflammation and more 
fibrous capsules compared with amalgam.48 In addition, the 
presence of cementum on the surface of MTA was a frequent 
finding.49 The most characteristic tissue reaction to MTA was 
the presence of connective tissue after the first postoperative 
week. Inflammation was seen occasionally. Early tissue healing 
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events after MTA root-end filling were characterized by hard 
tissue formation, activated progressively from the peripheral 
root walls along the MTA-soft tissue interface.
Conclusions
Both MTA and Portland cement are bioactive materials. The 
biocompatibility of the materials had originally been attributed 
to the chemical similarity to tooth hard tissues namely calcium 
phosphate. However this has been shown not to be the case. MTA 
produces calcium hydroxide as a by-product of the hydration 
reaction.4 The similarity of action of both MTA and Portland 
cement to calcium hydroxide had been postulated.31, 32 
Calcium hydroxide is used extensively in dentistry. When 
using SEM to study the biocompatibility of dental materials it is 
imperative to ensure there is no reaction between the material 
and the reagents used in the experimental procedure. Scanning 
electron microscopy thus is contraindicated to evaluate cell 
growth and expression over materials based on Portland 
cement. Other methods of assessing biocompatibility are thus 
preferred.
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